Reynolds says they're paying around €650,000 euros ($725,000) in cash and stock and the deal is expected to close in January 2020.
VolitionRx acquires epigenetic reagent company Octamer GmbH
Quick facts: VolitionRx
Price: 3.55 USD
Market Cap: $164.1 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of VolitionRx named herein, including the promotion by the Company of VolitionRx in any Content on the Site, the Company receives from said issuer...FOR OUR FULL DISCLAIMER CLICK HERE